Morgan Stanley has issued a research report stating that, due to CHINA LIFE's strong new business value growth in the first quarter, it has raised its related growth assumptions. Consequently, the firm has slightly increased its profit forecasts for CHINA LIFE for 2026, 2027, and 2028 by 0.1%, 0.3%, and 0.4% respectively. Morgan Stanley has raised CHINA LIFE's price target by 2.6%, from HK$37.90 to HK$38.90, and maintains its "Overweight" rating.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments